STOCK TITAN

Medtronic Stock Price, News & Analysis

MDT NYSE

Welcome to our dedicated page for Medtronic news (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic stock.

Medtronic plc (MDT) is a global leader in medical technology, developing innovative healthcare solutions that address chronic diseases and complex conditions. This dedicated news hub provides investors and professionals with timely updates on the company's strategic initiatives, regulatory milestones, and technological breakthroughs.

Access authoritative information spanning earnings announcements, product approvals, partnership developments, and clinical trial outcomes. Our curated collection ensures you stay informed about MDT's advancements in cardiac care, neuromodulation, diabetes management, and surgical robotics.

Discover press releases detailing regulatory submissions, executive appointments, and global market expansions. Each update is verified for accuracy, offering insights into how Medtronic maintains its position at the forefront of medical innovation while navigating evolving healthcare landscapes.

Bookmark this page for direct access to primary source materials and analysis-free reporting on MDT's operational developments. Regular updates ensure you never miss critical information impacting the medical technology sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.51%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.51%
Tags
dividends earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.35%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
AI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
Rhea-AI Summary

Medtronic plc (NYSE:MDT) has resolved a warning letter from the FDA regarding its Diabetes headquarters in Northridge, California, which was received in December 2021. The FDA's decision comes shortly after the agency approved the MiniMedâ„¢ 780G system, the first automated insulin delivery system with real-time meal detection technology. The new system adjusts glucose levels automatically every five minutes, addressing significant needs in diabetes management. Medtronic expresses gratitude for the collaborative efforts with the FDA, which enable the company to focus on delivering innovative solutions for diabetes patients. This resolution marks a crucial step for Medtronic's Diabetes division, ensuring adherence to quality standards and paving the way for future advancements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none

FAQ

What is the current stock price of Medtronic (MDT)?

The current stock price of Medtronic (MDT) is $85.81 as of May 12, 2025.

What is the market cap of Medtronic (MDT)?

The market cap of Medtronic (MDT) is approximately 107.0B.
Medtronic

NYSE:MDT

MDT Rankings

MDT Stock Data

107.03B
1.28B
0.26%
86.22%
1.05%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
Ireland
GALWAY